Van Lanschot Kempen Investment Banking (@Kempen_Co) header
Van Lanschot Kempen Investment Banking (@Kempen_Co) profile picture

Corporate Finance | Debt Advisory | Equity Capital Markets | Research | Trading | Structured Products Part of @VLKCorporate #lifesciences #realestate #fintech

Amsterdam, New York, London
Joined October 2019
Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)Photo by Van Lanschot Kempen Investment Banking (@Kempen_Co)
This account is no longer active. Follow @VLKcorporate if you want to stay informed about Van Lanschot Kempen. Or take a look at our website: vanlanschotkempen.com/en-nl/…
106
We acted as Joint Global Coordinator / Joint Bookrunner in #Hyloris IPO of €61.8 million. Its the first #IPO on #Euronext Brussels in 2020, and Kempen & Co's 8th overall transaction for European #lifesciences companies since the beginning of 2020. kempen.com/nl/corporate-fina…
1
1
The Oryzon Genomics’ Capital Increase of €20m is our 7th transaction for Euro #lifesciences companies in 2020 and our first ever for a Spanish LS company, underpinning our ambition to work with innovative LS companies in Europe. #biotech kempen.com/en/corporate-fina…
1
1
Our Life Sciences analyst Suzanne van Voorthuizen today in De Telegraaf about 'the hunt for eternal fame with a coronavaccin': "Biotech companies feel, above all, a moral obligation to work on a solution" telegraaf.nl/financieel/9891…
Van Lanschot Kempen Investment Banking retweeted
Register now! During the webinar on June 26, ProQr's Daniel de Boer delves into the impact of COVID-19 on financing in the #lifesciences w/ Geraldine O'Keeffe (LSP), Arthur Franken (Gilde Healthcare), Krijn De Nood (Meatable) & Jan De Kerpel (Kempen & Co). lnkd.in/d9k9u_W
3
2
Kempen & Co acted as Joint Global Coordinator in BioInvent’s Capital Increase of SEK 487 million. This deal marks our sixth transaction in the Nordics region over the past 18 months, where we maintain a strong ambition to work with innovative companies. kempen.com/en/corporate-fina…
Head of Kempen's Real Estate Research Robert Woerdeman is sceptical about the modest price increase in the retail real estate stock market (article in Dutch) deaandeelhouder.nl/nieuws/20…
Analist Jaap Kuin comments in @telegraaf today about the retail property sector in The Netherlands - written by @JohanWiering and @PietervanED @urw_group telegraaf.nl/financieel/1851…
3
1
Kempen & Co is pleased to announce it acted as Co-Manager the largest capital increase to date of its long-term client #argenx - setting a new landmark for European biotech by raising USD 750 million in gross proceeds kempen.com/en/corporate-fina…
2
Analyst Jaap Kuin in Dutch @FD_Nieuws about the price increase of @urw_group: 'Any snippet of positive news, for example about the reopening of shopping centers, can now lead to serious price increases. It mainly reflects the uncertainty in the market' fd.nl/beurs/1345944/vastgoed…
1
1
Life sciences analysts Suzanne van Voorthuizen and Alex Cogut were quoted in Dutch newspaper De Telegraaf about pricing of treatments and vaccins telegraaf.nl/financieel/1906…
Our managing director Securities Anneka Treon discusses in The @FinancialTimes the role of banks in this crisis; behaving more like shock absorbers than shock amplifiers, as they were over 2007-2008. ft.com/content/1ff7c4c9-92fc… #banking #covid19 #economy #leverage
1
3
Life Sciences analyst Suzanne van Voorthuizen comments in Dutch newspaper @nrc about the development of a vaccine for #Covid_19: ‘Investing in vaccines is an uncertain business and not always viable.’ nrc.nl/nieuws/2020/03/20/ope…
1
1
Van Lanschot Kempen Investment Banking retweeted
The search for a drug or vaccine for coronavirus is in full swing with more and more parties (like $BNTX) joining the global effort - with insights from our vaccines analyst Suzanne! #biotech #vaccines #coronavirus @BioNTech_Group
Nu de pandemie nauwelijks meer is in te dammen, richt de hoop van de wereld zich op een medicijn of vaccin. Maandag is in Amerika het eerste proefvaccin getest op mensen. Mogen we hopen op de snelle komst van een coronapil? telegraaf.nl/t/2026769018?ut…
Kempen analyst Alex Cogut comments on the development of #COVID19 tests in Dutch national newspaper @telegraaf: “German-Dutch biotech Qiagen probably the first with a test on the US market.” telegraaf.nl/financieel/1033…
1
1
Kempen adviser in sale @TerraPay by @MahindraComviva to @prime_ventures and @PartechPartners. Joined by @IFC_org also participated in a capital increase to fund TerraPay’s global expansion. Congratulations to TerraPay’s founders @AmbarSur, @ram_terrapay, Ani Sane & Akbar Hussain
1
4
Happy Valentine’s Day from the heart of European Life Sciences! The 13th Kempen Life Sciences conference will be held on 21 & 22 April. 2019: almost 50 companies and over 100 investors 2020: it promises to be even busier. kempen.com/en/securities/eve…
We would like to thank all of our clients for making Kempen & Co the most active ECM bank in the Benelux last year! kempen.com/en/corporate-fina… #ECM
1